Experiment 922829

Details

PropertyValue
Pharmacology
Administration routeROUTE NOT GIVEN
OrganismEmpty organism
CitationO'DWYER,PJ: KING,SA: HOTH,DF: SUFFNESS,M: LEYLAND-JONES,B:. (1986). HOMOHARRINGTONINE. PRESPECTIVES ON AN ACTIVE NEW NATURAL PRODUCT.. 4(10)
Amount utilized
Compound isolated
DiseaseIN A PHASE 1/2 TRIAL IN PATIENTS WITH ACUTE LEUKEMIA, DOSE LIMITING TOXICITY WAS HYPOTENSION. OF 28 PATIENTS TREATED WITH THE DOSAGE DAILY FOR 9 DAYS, 6 ENTERED REMISSION.
Dose amount5.0 MG
Number16
Qualitative result.
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE